Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities    
Net loss $ (22,051) $ (30,680)
Adjustments to reconcile net loss used in operating activities:    
Depreciation and amortization 67 451
Stock-based compensation 5,312 1,448
Accretion of debt discount 350 0
Deferred taxes 9 21
Changes in assets and liabilities:    
Accounts receivable, net 123 (953)
Other receivables 2,294 152
Inventory, net 13 3
Prepaid expenses and other assets (310) 195
Accounts payable 388 9,339
Accrued expenses and other liabilities (2,287) 1,724
Lease liability, net 25 (16)
Net cash used in operating activities (16,067) (18,316)
Investing activities    
Purchase of property and equipment 0 (21)
Net cash used in investing activities 0 (21)
Financing activities    
Proceeds from issuance of common stock and pre-funded warrants in underwritten public offering, net 0 37,653
Proceeds from exercise of stock options and warrants 0 172
Net cash provided by financing activities 0 37,825
(Decrease) increase in cash, cash equivalents and restricted cash (16,067) 19,488
Cash, cash equivalents, and restricted cash at beginning of period 54,863 19,106
Cash, cash equivalents, and restricted cash at end of period 38,796 38,594
Supplemental disclosures of cash flow information    
Cash paid for interest 831 0
Cash and cash equivalents 38,469 38,292
Restricted cash, current 100 153
Restricted cash, non-current 227 149
Total cash, cash equivalents and restricted cash $ 38,796 $ 38,594